Voices of Wisdom: A Podcast for Thyroid Clinicians

Beyond Bethesda: Cytopathologic Diagnosis of Thyroid Tumors

Thyroid cytology can be clear at the extremes, but uncertainty dominates the middle ground. In this episode, Dr. Zubair Baloch explores why indeterminate nodules challenge clinicians and how context, judgment, and collaboration shape better decisions. It’s a thoughtful look at what lies beyond Bethesda—and why everything matters.

Personalizing Thyroid Hormone Therapy in Cancer Care

In this episode, Dr. Dana Hartl speaks with Dr. J.P. Brito from the Mayo Clinic about the art and science of thyroid hormone replacement therapy. Together, they explore balancing TSH suppression, managing persistent symptoms, and understanding when “normal” lab results don’t tell the full story. Tune in for expert insights that challenge assumptions and highlight the power of individualized care.

Intraoperative Neuromonitoring: What Clinicians Should Know

What if surgeons could see nerve function in real time—and prevent injury before it happens? In this episode, Dr. Catherine Sinclair reveals how intraoperative neuromonitoring is reshaping thyroid surgery worldwide. From technical nuances to global access challenges, listeners gain a rare insider’s look at how innovation is transforming surgical precision.

Expert Tips & Tricks for Thyroid Cancer Ultrasound

Dr. Lisa Orloff shares practical, experience-driven tips for optimizing thyroid cancer ultrasound—from honing diagnostic skills and scanning overlooked areas to guiding surgery and follow-up care. Her expert insights help clinicians improve accuracy, integrate ultrasound into patient management, and adopt interactive techniques for better outcomes.

Understanding Financial Toxicity in Thyroid Cancer

What happens when a cancer diagnosis impacts more than just your health? In this episode, Dr. Carrie Cunningham joins us to explore financial toxicity in thyroid cancer—what it is, why it matters, and how we can measure it. She also shares surprising insights about global policies and the promising role of AI in reducing patient burden.

Unresectable vs. Resectable Thyroid Cancer (Pt. 2)

What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights & evolving surgical strategies you won't want to miss.

Unresectable vs. Resectable Thyroid Cancer (Pt. 1)

What makes a thyroid tumor truly unresectable? In this episode, Dr. Dana Hartl speaks with Dr. Mark Zafereo about how molecular testing and targeted neoadjuvant therapies are redefining surgical eligibility for patients with anaplastic thyroid cancer. Listen in as they explore the evolving role of BRAF/MEK inhibitors, imaging strategies, and real-world decision-making in complex cases.

Around the World in 3 Clinical Case Scenarios (Pt. 2)

In the continuation of this episode of Voices of Wisdom, Dr. Dana Hartl hosts Drs. Fabian Pitoia and Iwao Sugitani for a global discussion on thyroid cancer management. Together, they examine real-world cases and explore differing international approaches to active surveillance, surgery and treatment strategies. Gain insight into how cultural values and evolving guidelines shape care decisions around the world.

Around the World in 3 Clinical Case Scenarios (Pt. 1)

In this thought-provoking episode of Voices of Wisdom, Dr. Dana Hartl hosts Drs. Fabian Pitoia and Iwao Sugitani for a global discussion on thyroid cancer management. Together, they examine real-world cases and explore differing international approaches to active surveillance, surgery and treatment strategies. Gain insight into how cultural values and evolving guidelines shape care decisions around the world.

Radioactive Iodine: Unraveling the Mystery (Part 2)

In Part 2 of this episode of Voices of Wisdom, Dr. Dana Hartl continues her conversation with Dr. David Pattison, diving deeper into radioactive iodine therapy for thyroid cancer. They discuss the biological mechanisms of I-131, key differences from external beam radiation, and evolving strategies for personalized treatment. Dr. Pattison also explores future advancements, including re-differentiation therapy and the role of nuclear medicine in optimizing patient care.
Feel free to send your questions or suggestions about future episodes to voicesofwisdompodcast@gmail.com.
To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe